Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 29 studies | 31% ± 11% | |
pericyte | 24 studies | 28% ± 9% | |
fibroblast | 22 studies | 30% ± 11% | |
endothelial cell | 15 studies | 33% ± 12% | |
endothelial cell of lymphatic vessel | 13 studies | 25% ± 7% | |
ciliated cell | 13 studies | 25% ± 6% | |
type I pneumocyte | 9 studies | 42% ± 16% | |
type II pneumocyte | 9 studies | 32% ± 11% | |
cardiac muscle cell | 6 studies | 80% ± 13% | |
myofibroblast cell | 5 studies | 28% ± 7% | |
endothelial cell of artery | 5 studies | 28% ± 7% | |
muscle cell | 4 studies | 45% ± 27% | |
mesothelial cell | 3 studies | 22% ± 6% | |
capillary endothelial cell | 3 studies | 19% ± 3% | |
endothelial cell of vascular tree | 3 studies | 31% ± 1% | |
glutamatergic neuron | 3 studies | 23% ± 6% | |
connective tissue cell | 3 studies | 22% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 1941.29 | 571 / 578 | 46% | 1.64 | 530 / 1155 |
thymus | 81% | 716.97 | 528 / 653 | 49% | 1.12 | 299 / 605 |
esophagus | 71% | 2104.43 | 1027 / 1445 | 49% | 1.23 | 90 / 183 |
breast | 77% | 784.45 | 354 / 459 | 40% | 0.72 | 452 / 1118 |
uterus | 93% | 2226.11 | 158 / 170 | 19% | 1.50 | 85 / 459 |
bladder | 90% | 3865.71 | 19 / 21 | 19% | 0.54 | 98 / 504 |
muscle | 100% | 7397.55 | 803 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3518.24 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 6447.13 | 856 / 861 | 0% | 0 | 0 / 0 |
adipose | 96% | 1403.31 | 1161 / 1204 | 0% | 0 | 0 / 0 |
intestine | 75% | 2782.45 | 726 / 966 | 16% | 0.36 | 83 / 527 |
kidney | 20% | 145.79 | 18 / 89 | 62% | 2.57 | 557 / 901 |
ovary | 18% | 200.62 | 32 / 180 | 54% | 1.92 | 234 / 430 |
stomach | 40% | 1025.78 | 142 / 359 | 28% | 1.20 | 81 / 286 |
prostate | 41% | 656.22 | 101 / 245 | 23% | 0.43 | 114 / 502 |
pancreas | 8% | 49.08 | 26 / 328 | 39% | 0.79 | 70 / 178 |
adrenal gland | 4% | 30.12 | 11 / 258 | 35% | 0.81 | 80 / 230 |
brain | 19% | 158.03 | 508 / 2642 | 15% | 0.24 | 108 / 705 |
tonsil | 0% | 0 | 0 / 0 | 22% | 0.52 | 10 / 45 |
liver | 5% | 30.23 | 11 / 226 | 17% | 0.32 | 67 / 406 |
skin | 4% | 30.44 | 64 / 1809 | 7% | 0.13 | 31 / 472 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
peripheral blood | 1% | 12.13 | 11 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0099010 | Biological process | modification of postsynaptic structure |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005730 | Cellular component | nucleolus |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
Gene name | FILIP1 |
Protein name | Filamin-A-interacting protein 1 (FILIP) Filamin A interacting protein 1 |
Synonyms | hCG_17988 KIAA1275 |
Description | FUNCTION: By acting through a filamin-A/F-actin axis, it controls the start of neocortical cell migration from the ventricular zone. May be able to induce the degradation of filamin-A. . |
Accessions | Q7Z7B0 ENST00000237172.12 [Q7Z7B0-1] ENST00000370020.1 A0A075B6G6 ENST00000393004.6 [Q7Z7B0-2] |